Menghua Xiang

475 total citations
18 papers, 386 citations indexed

About

Menghua Xiang is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Menghua Xiang has authored 18 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in Menghua Xiang's work include Click Chemistry and Applications (8 papers), Protein Degradation and Inhibitors (5 papers) and Chemical Synthesis and Analysis (2 papers). Menghua Xiang is often cited by papers focused on Click Chemistry and Applications (8 papers), Protein Degradation and Inhibitors (5 papers) and Chemical Synthesis and Analysis (2 papers). Menghua Xiang collaborates with scholars based in China, Singapore and Thailand. Menghua Xiang's co-authors include Liqian Gao, Wei Wang, Qicai Xiao, Shao Q. Yao, Fen Yang, Xuan Wang, Chengjun Zhu, Wenbin Deng, Yan Jia and Jun Shen and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Chemical Communications.

In The Last Decade

Menghua Xiang

17 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Menghua Xiang China 10 222 107 72 64 64 18 386
Lulu Li China 14 382 1.7× 57 0.5× 48 0.7× 39 0.6× 73 1.1× 22 565
Emilia Calvaresi United States 7 388 1.7× 186 1.7× 61 0.8× 50 0.8× 73 1.1× 11 648
Jianqiang Qian China 14 200 0.9× 180 1.7× 87 1.2× 52 0.8× 38 0.6× 27 458
Luke S Kennedy Canada 3 299 1.3× 57 0.5× 158 2.2× 93 1.5× 67 1.0× 5 604
Hongxia Liu China 16 520 2.3× 223 2.1× 49 0.7× 86 1.3× 92 1.4× 25 821
Wenda Zhang China 15 295 1.3× 156 1.5× 30 0.4× 33 0.5× 151 2.4× 23 555
Qijie Gong China 6 134 0.6× 101 0.9× 101 1.4× 51 0.8× 25 0.4× 10 322
Qin Tang China 12 200 0.9× 63 0.6× 60 0.8× 40 0.6× 29 0.5× 20 387
Rhushikesh A. Kulkarni United States 11 287 1.3× 113 1.1× 32 0.4× 39 0.6× 75 1.2× 16 442
William Wolter United States 9 168 0.8× 45 0.4× 39 0.5× 52 0.8× 43 0.7× 14 417

Countries citing papers authored by Menghua Xiang

Since Specialization
Citations

This map shows the geographic impact of Menghua Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Menghua Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Menghua Xiang more than expected).

Fields of papers citing papers by Menghua Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Menghua Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Menghua Xiang. The network helps show where Menghua Xiang may publish in the future.

Co-authorship network of co-authors of Menghua Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Menghua Xiang. A scholar is included among the top collaborators of Menghua Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Menghua Xiang. Menghua Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Chen, Peng, Lu Wang, Xuan Wang, et al.. (2025). Cell‐Active, Arginine‐Targeting Irreversible Covalent Inhibitors for Non‐Kinases and Kinases. Angewandte Chemie International Edition. 64(13). e202422372–e202422372. 3 indexed citations
2.
Chen, Peng, Lu Wang, Xuan Wang, et al.. (2025). Cell‐Active, Arginine‐Targeting Irreversible Covalent Inhibitors for Non‐Kinases and Kinases. Angewandte Chemie. 137(13). 3 indexed citations
3.
Xiang, Menghua, Fen Yang, Peng Chen, et al.. (2025). Tumor microenvironment-responsive self-assembled nanomedicine for reversible covalent targeting of BCR-ABL kinase. Chinese Chemical Letters. 37(2). 111423–111423. 1 indexed citations
4.
Wang, Xuan, Guanghui Tang, Peng Chen, et al.. (2024). Kinase Inhibition via Small Molecule‐Induced Intramolecular Protein Cross‐Linking. Angewandte Chemie International Edition. 63(28). e202404195–e202404195.
5.
Wang, Xuan, Guanghui Tang, Peng Chen, et al.. (2024). Kinase Inhibition via Small Molecule‐Induced Intramolecular Protein Cross‐Linking. Angewandte Chemie. 136(28). 1 indexed citations
6.
Wang, Wei, Xuan Wang, Guanghui Tang, et al.. (2023). Multitarget inhibitors/probes that target LRRK2 and AURORA A kinases noncovalently and covalently. Chemical Communications. 59(72). 10789–10792. 4 indexed citations
7.
Chen, Peng, Guanghui Tang, Chengjun Zhu, et al.. (2023). 2-Ethynylbenzaldehyde-Based, Lysine-Targeting Irreversible Covalent Inhibitors for Protein Kinases and Nonkinases. Journal of the American Chemical Society. 145(7). 3844–3849. 41 indexed citations
8.
Xiang, Menghua, et al.. (2023). Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology. Frontiers in Pharmacology. 14. 1137707–1137707. 12 indexed citations
9.
Chen, Peng, Chengjun Zhu, Guanghui Tang, et al.. (2022). Cell‐Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR‐ABL Kinase. Angewandte Chemie International Edition. 61(26). 55 indexed citations
10.
Chen, Peng, Jie Sun, Chengjun Zhu, et al.. (2022). Cell‐Active, Reversible, and Irreversible Covalent Inhibitors That Selectively Target the Catalytic Lysine of BCR‐ABL Kinase. Angewandte Chemie. 134(26). e202203878–e202203878. 13 indexed citations
11.
Yuan, Chuang, Kelong Ai, Menghua Xiang, et al.. (2022). Novel 1-hydroxy phenothiazinium-based derivative protects against bacterial sepsis by inhibiting AAK1-mediated LPS internalization and caspase-11 signaling. Cell Death and Disease. 13(8). 722–722. 9 indexed citations
12.
Xiao, Qicai, Xiao Dong, Fen Yang, et al.. (2021). Engineered Cell‐Penetrating Peptides for Mitochondrion‐Targeted Drug Delivery in Cancer Therapy. Chemistry - A European Journal. 27(59). 14721–14729. 26 indexed citations
13.
Xiao, Qicai, Bingjie Mai, Yichu Nie, et al.. (2021). In Vitro and In Vivo Demonstration of Ultraefficient and Broad-Spectrum Antibacterial Agents for Photodynamic Antibacterial Chemotherapy. ACS Applied Materials & Interfaces. 13(10). 11588–11596. 43 indexed citations
14.
Shi, Wen‐Jing, Xuan Wang, Yan Huang, et al.. (2021). A near-infrared-emission aza-BODIPY-based fluorescent probe for fast, selective, and “turn-on” detection of HClO/ClO−. Talanta. 233. 122581–122581. 50 indexed citations
15.
Xiang, Menghua, Xuan Wang, Fen Yang, et al.. (2021). A Review of Light Sources and Enhanced Targeting for Photodynamic Therapy. Current Medicinal Chemistry. 28(31). 6437–6457. 14 indexed citations
16.
Yang, Fen, Wei Wang, Menghua Xiang, et al.. (2020). Recent advance on PTP1B inhibitors and their biomedical applications. European Journal of Medicinal Chemistry. 199. 112376–112376. 106 indexed citations
17.
Liang, Zhiyan, et al.. (2019). Tissue Distribution Study of Apocynin By RP-HPLC With UV Detector. Journal of Pharmaceutical and Biomedical Sciences. 9(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026